Taxus Cardium Pharmaceuticals Group Inc.
SEC CIK 772320 · CXM · last insider filing 2021-04-28
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Grainer James L | Director · Chairman of the Board & CFO | filed 2020 - 2020 |
| Vyas Kaushik K. | Director | filed 2020 - 2020 |
| Reinhard Christopher J | Director · Chief Executive Officer | filed 2008 - 2015 |
| Hutchison Murray H | Director | filed 2006 - 2015 |
| Lewis Gerald J | Director | filed 2006 - 2015 |
| Leitch Andrew M | Director | filed 2007 - 2015 |
| Gabrielson Edward W | Director | filed 2006 - 2015 |
| Otremba Lon E | Director | filed 2006 - 2015 |
| Dylan Tyler Michael | Director · Chief Business Officer | filed 2008 - 2014 |
| Simon Ronald I | Director | filed 2006 - 2009 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Shebuski Ronald J. | Chief Scientific Officer | filed 2020 - 2020 |
| Mulroy Dennis | Chief Financial Officer | filed 2009 - 2014 |
| Rubanyi Gabor M | Chief Scientific Officer | filed 2006 - 2014 |
| Moreadith Randall | Exec VP and Chief Med Officer | filed 2006 - 2008 |
| Magers Michael | President/COO of Subsidiary | filed 2006 - 2007 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.